|
Characteristic Study ID |
Duration of diabetes [mean years (SD)/range] | Severity of target condition | Symptoms (spectrum of DPN) | Prevalence in study centre | Follow‐up | Glycaemic control | Antihyperglycaemic treatment | Co‐morbidities | Co‐medications / Co‐interventions |
| Study 1 | |||||||||
| Study 2 | |||||||||
| Study 3 | |||||||||
| Study 4 | |||||||||
| "‐" denotes not reported DPN: diabetic peripheral neuropathy; SD: standard deviation. | |||||||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.